Literature DB >> 9285256

Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.

V Böhm1, K Tiroke, S Schneider, H Sperschneider, G Stein, R Bitsch.   

Abstract

The vitamin C status of patients with chronic renal failure (CRF), dialysis patients (DP) and patients after renal transplantation (RT) was the object of this investigation. Levels of vitamin C intake from dietary records were estimated at mean values of 93.5 mg/d (CRF), 65.5 mg/d (DP) and 163.9 mg/d (RT). Compared to the recommendation of the German Society of Nutrition (75 mg/d), this indicated a normal range of supply for all groups except the group of DP. The corresponding mean plasma concentrations were 62.2 mumol/l (CRF), 80.3 mumol/l (DP) and 68.8 mumol/l (RT). Supplements of 60 or 100 mg vitamin C given to patients of the DP-group after each dialysis session showed slightly, but not significantly higher concentrations of vitamin C in plasma. During dialysis treatment, plasma vitamin C concentrations dropped to approximately 50% of the basal value, but almost reached initial levels again 44 hours later, both with and without supplementation. During one treatment period, vitamin C loss in the dialysate of three patients ranged between 92.5 and 333.6 mg. The amount of vitamin C in plasma, however, dropped to approximately 50% of the basal value for these patients, too.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285256

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  13 in total

Review 1.  Vitamin and trace element deficiencies in the pediatric dialysis patient.

Authors:  Lyndsay A Harshman; Kathy Lee-Son; Jennifer G Jetton
Journal:  Pediatr Nephrol       Date:  2017-07-27       Impact factor: 3.714

2.  Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.

Authors:  Tanjim Sultana; Maria V DeVita; Michael F Michelis
Journal:  Int Urol Nephrol       Date:  2016-05-11       Impact factor: 2.370

3.  Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis.

Authors:  Fredric O Finkelstein; Peter Juergensen; Suxin Wang; Sally Santacroce; Mark Levine; Peter Kotanko; Nathan W Levin; Garry J Handelman
Journal:  Perit Dial Int       Date:  2010-06-17       Impact factor: 1.756

4.  Reduction of serum antioxidative capacity during hemodialysis.

Authors:  Keisuke Nakayama; Hiroyuki Terawaki; Masaaki Nakayama; Masashi Iwabuchi; Toshinobu Sato; Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

5.  Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients.

Authors:  M Jalalzadeh; E Shekari; F Mirzamohammadi; M H Ghadiani
Journal:  Indian J Nephrol       Date:  2012-05

6.  Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparison of two dialysis membranes.

Authors:  H Ibrahim Varan; Belda Dursun; Evrim Dursun; Tomris Ozben; Gultekin Suleymanlar
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-04-12

7.  Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study.

Authors:  Vajihe Biniaz; Mehdi Sadeghi Shermeh; Abbas Ebadi; Ali Tayebi; Behzad Einollahi
Journal:  Nephrourol Mon       Date:  2013-11-27

8.  Vitamin C overload may contribute to systemic oxalosis in children receiving dialysis.

Authors:  Sabina S Kennedy; Ashley Perilloux; Renata C Pereira; Garry Handelman; Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2020-08-09       Impact factor: 3.714

9.  End-stage renal disease in Taiwan: a case-control study.

Authors:  Su-Ying Tsai; Hung-Fu Tseng; Hsiu-Fen Tan; Yu-Shu Chien; Chia-Chu Chang
Journal:  J Epidemiol       Date:  2009-06-20       Impact factor: 3.211

10.  The effect of vitamin C on parathyroid hormone in patients on hemodialysis with secondary hyperparathyroidism: a double blind, placebo-controlled study.

Authors:  Vajihe Biniaz; Eghlim Nemati; Ali Tayebi; Mehdi Sadeghi Shermeh; Abbas Ebadi
Journal:  Nephrourol Mon       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.